Forte Biosciences FBRX
FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Total Non-Current Liabilities (2018 - 2026)

Updated

Forte Biosciences' Total Non-Current Liabilities came in at $20.29 million for Q2 2026, down 14.2% from the prior quarter.

Analysis

Forte Biosciences (FBRX) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

At the end of FY2025, Forte Biosciences' Total Non-Current Liabilities was $20.75 million.

  • The Q2 2026 figure represents the lowest quarterly Total Non-Current Liabilities since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Forte Biosciences 1.58 Bn 1.38 Bn - 20.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.29 Mn
Mar 31, 2026 23.65 Mn
Dec 31, 2025 20.75 Mn
Dec 31, 2019 12.35 Mn
Sep 30, 2019 73.90 Mn
Mar 31, 2019 94.35 Mn
Dec 31, 2018 101.62 Mn
Sep 30, 2018 40.66 Mn
Jun 30, 2018 39.70 Mn
Mar 31, 2018 18.90 Mn
API Access

Forte Biosciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=FBRX&period=max&api_key=YOUR_API_KEY